Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026
(NASDAQ: ASMB) Delayed: 25.15 +0.71 (2.91%)
Previous Close $24.44    52 Week High $14.50 
Open $24.50    52 Week Low $4.33 
Day High $26.14    P/E N/A 
Day Low $24.44    EPS $0.00 
Volume 286,842